View Older Stories View More Recent Stories

Jan 9, 2026 04:57AM Jazz Pharmaceuticals (JAZZ) PT Raised to $263 at BofA Securities
Jan 8, 2026 04:07PM Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer
Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC
Jan 7, 2026 04:13AM BofA on Jazz (JAZZ): 'We continue to see $1bn+ peak sales potential for zani in 1L GE'
Jan 6, 2026 02:18PM Baird's Brian Skorney on Jazz Pharmaceuticals (JAZZ): 'We are buyers on weakness'
Jan 6, 2026 01:33PM Jazz Pharmaceuticals reports positive Ziihera cancer trial results
Jan 6, 2026 11:46AM RBC on Jazz (JAZZ): 'Downside Move on HERIZON-GEA Data Leak Unwarranted - Zani Regimens Are Clearly Active and Will See Use'
Dec 10, 2025 07:30AM Jazz Pharmaceuticals (JAZZ) PT Raised to $219 at Piper Sandler
Dec 5, 2025 09:01AM Jazz Pharmaceuticals to present Epidiolex data at epilepsy conference
Nov 24, 2025 05:53AM UBS Downgrades Jazz Pharmaceuticals (JAZZ) to Neutral
Nov 18, 2025 05:00AM Jazz Pharmaceuticals (JAZZ) PT Raised to $235 at Wells Fargo
Nov 18, 2025 04:59AM Jazz Pharmaceuticals (JAZZ) PT Raised to $247 at BofA Securities
Nov 18, 2025 04:11AM Jazz Pharmaceuticals (JAZZ) PT Raised to $209 at Baird
Nov 17, 2025 11:04AM Jazz Pharmaceuticals (JAZZ) PT Raised to $194 at RBC Capital
Nov 12, 2025 05:00AM Werewolf Therapeutics' (HOWL) an 'Attractive Investment Opportunity'- Citizens
Nov 11, 2025 07:45AM Jazz Pharmaceuticals presents Modeyso data at neuro-oncology meeting
Nov 5, 2025 04:33PM Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by $2.20, provides guidance
Oct 22, 2025 03:19PM RBC Capital on Jazz Pharmaceuticals (JAZZ): 'we would be buyers on the potential upcoming positive ph.III zanidatimab data in GEA'
Oct 3, 2025 08:05AM Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Oct 2, 2025 03:33PM FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-TAJS for extensive-stage small cell lung cancer
Sep 23, 2025 04:04PM Jazz Pharmaceuticals (JAZZ) PT Raised to $167 at Morgan Stanley
Sep 22, 2025 07:45AM Jazz Pharmaceuticals presents Xywav data at medical conferences
Sep 15, 2025 08:29AM Piper Sandler Reiterates Overweight Rating on Jazz Pharmaceuticals (JAZZ)
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Sep 9, 2025 07:45AM Jazz Pharmaceuticals' Modeyso added to NCCN cancer guidelines
Aug 28, 2025 09:25AM Jazz Pharmaceuticals (JAZZ) PT Raised to $205 at Truist Securities
Aug 28, 2025 08:54AM Jazz Pharmaceuticals (JAZZ) PT Raised at RBC Capital on 'Meaningful Upside' Potential
Aug 28, 2025 07:36AM Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Aug 20, 2025 07:30AM Jazz Pharmaceuticals licenses epilepsy drug from Saniona for $42.5M
Aug 14, 2025 06:14AM Jazz Pharmaceuticals (JAZZ) PT Raised to $225 at BofA Securities
Aug 6, 2025 02:24PM FDA approves Jazz Pharmaceuticals' dordaviprone for rare brain cancer
Aug 5, 2025 04:29PM Jazz Pharmaceuticals (JAZZ) Misses Q2 EPS by 63c
Jul 15, 2025 04:05AM Deutsche Bank Starts Jazz Pharmaceuticals (JAZZ) at Buy
Jul 10, 2025 07:30AM Jazz Pharmaceuticals names Renee Gala as CEO, Bruce Cozadd to retire
Jul 1, 2025 08:32AM Jazz Pharmaceuticals (JAZZ) Receives EU Marketing Authorization for Ziihera
Jun 11, 2025 07:15AM Stifel Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Jun 10, 2025 07:05AM Jazz Pharmaceuticals (JAZZ) Reports Zepzelca and Atezolizumab Combination Granted FDA Priority Review
Jun 9, 2025 06:27PM Jazz Pharmaceuticals (JAZZ) presents phase 4 Xywav data
Jun 3, 2025 08:19AM UBS Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Jun 2, 2025 04:05PM Jazz Pharmaceuticals (JAZZ) Announces Zepzelca and Atezolizumab Combination Significantly Improves Survival as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Jun 2, 2025 12:38PM Jazz Pharmaceuticals (JAZZ) Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera in mGEA
May 25, 2025 03:00PM Biotech stocks Q1 earnings review
May 6, 2025 04:30PM Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 313c; offers guidance
Apr 22, 2025 09:34AM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
Apr 21, 2025 04:05PM Jazz Pharmaceuticals (JAZZ) Completes Acquisition of Chimerix
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 05:26AM BofA on Jazz Pharmaceuticals (JAZZ): 'sell-off looks overblown'
Apr 8, 2025 10:19AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $166 at UBS
Mar 13, 2025 06:58AM Cantor Biotech industry report, buying value in RevGens
Mar 11, 2025 06:41AM Jazz Pharmaceuticals (JAZZ) PT Raised to $217 at H.C. Wainwright
View More Recent Stories View Older Stories